Balaxi Pharmaceuticals Ltd.

BALAXI

Market Cap
₹635 Cr.
P/E
0.00

Balaxi Pharmaceuticals Ltd.

Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked

Company Timeline

Company Timeline

Subscribe now for more updates
Forensics
Other Income
Other Income is not affecting ratios of the company
Capex vs ROCE
Company has made significant capex which might be affecting its ROCE
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Company is converting accounting profit to cash
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years but more due to rerating
ROE
Financial Leverage has increased ROE over 10 years
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Contingent Liabilities
Unable to calculate due to limited data
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
28.29%
3yr Average
42.72%
5yr Average
41.22%
Net Profit Margin
Latest
15.38%
3yr Average
16.24%
5yr Average
15.32%
ROCE
Latest
31.25%
3yr Average
49.58%
5yr Average
49.99%
Debt to Equity
Latest
0.06
3yr Average
0.05
5yr Average
0.03
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic

Drug Delivery Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Peer Comparison
Company Filing
Show Previous Years
Discussions & Analysis
timeline